These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 8380567

  • 1. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF, Curran WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis WD, Mohiuddin M.
    Int J Radiat Oncol Biol Phys; 1993 Jan 15; 25(2):193-207. PubMed ID: 8380567
    [Abstract] [Full Text] [Related]

  • 2. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ.
    Cancer; 1996 Apr 15; 77(8):1535-43. PubMed ID: 8608540
    [Abstract] [Full Text] [Related]

  • 3. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 4. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, Shapiro WR, Mealey J, Ransohoff J, Paoletti P.
    Int J Radiat Oncol Biol Phys; 1989 Jun 01; 16(6):1389-96. PubMed ID: 2542193
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.
    Curran WJ, Scott CB, Nelson JS, Weinstein AS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Powlis WD.
    Cancer; 1992 Dec 15; 70(12):2909-17. PubMed ID: 1451073
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.
    Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):853-60. PubMed ID: 15465203
    [Abstract] [Full Text] [Related]

  • 7. Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas.
    Genc M, Zorlu AF, Atahan IL.
    Radiother Oncol; 2000 Aug 01; 56(2):233-8. PubMed ID: 10927143
    [Abstract] [Full Text] [Related]

  • 8. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, Lamborn K, Wilson CB, Phillips TL, Larson DA.
    Int J Radiat Oncol Biol Phys; 2001 Jan 01; 49(1):71-7. PubMed ID: 11163499
    [Abstract] [Full Text] [Related]

  • 9. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
    Murray KJ, Nelson DF, Scott C, Fischbach AJ, Porter A, Farnan N, Curran WJ.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):453-9. PubMed ID: 7852106
    [Abstract] [Full Text] [Related]

  • 10. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ.
    J Neurooncol; 2018 Mar 01; 137(1):39-47. PubMed ID: 29404979
    [Abstract] [Full Text] [Related]

  • 11. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium.
    Halperin EC, Herndon J, Schold SC, Brown M, Vick N, Cairncross JG, Macdonald DR, Gaspar L, Fischer B, Dropcho E, Rosenfeld S, Morowitz R, Piepmeier J, Hait W, Byrne T, Salter M, Imperato J, Khandekar J, Paleologos N, Burger P, Bentel GC, Friedman A.
    Int J Radiat Oncol Biol Phys; 1996 Mar 01; 34(4):793-802. PubMed ID: 8598355
    [Abstract] [Full Text] [Related]

  • 12. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1994 Oct 15; 30(3):583-90. PubMed ID: 7928489
    [Abstract] [Full Text] [Related]

  • 13. Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Shibamoto Y.
    Am J Clin Oncol; 1995 Oct 15; 18(5):449-53. PubMed ID: 7572767
    [Abstract] [Full Text] [Related]

  • 14. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC, Gaspar L, Imperato J, Salter M, Herndon J, Dowling S.
    Am J Clin Oncol; 1993 Aug 15; 16(4):277-83. PubMed ID: 8392285
    [Abstract] [Full Text] [Related]

  • 15. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.
    Langer CJ, Ruffer J, Rhodes H, Paulus R, Murray K, Movsas B, Curran W.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):113-9. PubMed ID: 11516860
    [Abstract] [Full Text] [Related]

  • 16. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y.
    Cancer; 1983 Sep 15; 52(6):997-1007. PubMed ID: 6349785
    [Abstract] [Full Text] [Related]

  • 17. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):57-63. PubMed ID: 9422558
    [Abstract] [Full Text] [Related]

  • 18. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO.
    Bone Marrow Transplant; 2003 Apr 01; 31(7):559-64. PubMed ID: 12692621
    [Abstract] [Full Text] [Related]

  • 19. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
    Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson DF, Martin L, Curran WJ.
    Cancer; 1994 Nov 15; 74(10):2828-35. PubMed ID: 7954244
    [Abstract] [Full Text] [Related]

  • 20. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
    Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R.
    J Clin Oncol; 2002 May 01; 20(9):2267-76. PubMed ID: 11980997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.